Controlled absorption diltiazem pharmaceutical formulation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7067151
SERIAL NO

09606629

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A controlled absorption diltiazem pellet formulation for oral administration comprises a core having diltiazem or a pharmaceutically acceptable salt thereof as the active ingredient. The core is surrounded by a coating which has only a single layer which is comprised of a relatively major proportion of talc and relatively minor proportion of sodium lauryl sulfate admixed with a minor proportion of a pharmaceutically acceptable film-forming, first polymer permeable to water and diltiazem, and a major proportion of a pharmaceutically acceptable film-forming, second polymer that is less permeable to water and diltiazem than the first polymer. The core and the coating layer both exclude organic acids. The composition of the coating layer as well as the proportion of core to coating layer are effective to permit release of the diltiazem allowing controlled absorption following oral administration. By combining short lag and long lag pellets into a single formulation, the release of diltiazem is controlled over a twenty four hour period.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ACTAVIS ELIZABETH LLC200 ELMORA AVENUE ELIZABETH NJ 07207

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Heinicke, Grant W Fairview Park, AU 3 74
Lepore, Angelo Magill, AU 11 166
Morella, Angelo M Athelstone, AU 8 953

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation